The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,556.00
Bid: 12,588.00
Ask: 12,590.00
Change: -34.00 (-0.27%)
Spread: 2.00 (0.016%)
Open: 12,626.00
High: 12,646.00
Low: 12,474.00
Prev. Close: 12,590.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Taper Tantrum? Not just yet

Fri, 15th Jan 2021 07:52

* European stock futures down 0.5%

*

Jan 15 - Welcome to the home for real-time coverage of
markets brought to you by Reuters reporters. You can share your
thoughts with us at markets.research@thomsonreuters.com

TAPER TANTRUM? NOT JUST YET (0748 GMT)

Finally, markets have the news they've been waiting days
for: U.S. President-elect Joe Biden is proposing a $1.9 trillion
stimulus plan to jump-start the world's largest economy and
accelerate its response to COVID-19.

This is at the upper end of expectations. But in a
buy-the-rumour, sell-the-fact reaction, equities have eased a
touch and U.S. Treasury yields, which have shot higher on belief
that a big fiscal package will boost inflation, are also off
recent highs.

And for those looking for a taper tantrum, Federal Reserve
Chair Jerome Powell is not buying it, saying late on Thursday it
was too early for the Fed to adjust its monthly bond purchases.

His comments have paused a rally in the dollar for now.
Elsewhere, Bitcoin is recovering after a nearly $12,000 plunge
from the record $42,000 hit last week.

Concern over rising COVID-19 cases in China and signs of
fresh strains with Washington may also explain signs of caution
in markets. Executives of state-owned enterprises, officials of
the Chinese Communist Party and military, and oil giant CNOOC
will face new restrictions from the Trump
administration for allegedly using coercion against states with
rival South China Sea claims.

In Europe, political uncertainty in Italy remains in focus
although a snap election is still viewed as unlikely. Focus also
turns to Germany, where chancellor Angela Merkel's Christian
Democratic Union party on Saturday votes for a new leader and
will be a likely contender for next Chancellor.

Shares in German software group SAP are up 2% in
pre-market trade after preliminary annual results came at the
high end of guidance.

JP Morgan, Citigroup and Wells Fargo
report fourth-quarter results. Expectations are for financials
earnings to have dropped more than 6% but that's better than
what's forecast for the S&P 500 overall.

Key developments that should provide more direction to
markets on Friday:

- UK economy shrinks 2.6% in Nov, first drop since April.

- Italy's Renzi does not believe PM Conte has backing to win
no-confidence vote - La Stampa.

- U.S. retail sales, PPI 1330 GMT

- Fitch to review UK credit rating

- An emerging market rally lifted assets under management
(AUM) at money manager Ashmore by 9% in Q4

(Dhara Ranasinghe)

*****

EUROPE IN THE RED ON BIDEN’S CHALLENGES, PANDEMIC

European stock futures are in the red as markets focus on
the challenges U.S. president-elect Joe Biden will face in
getting approved a $1.9 trillion stimulus package, while
pandemic concerns continue to weigh on sentiment.

Investors are also concerned about possible tax increases
they expect to be part of Biden’s future plans.

China reporting the highest number of COVID-19 cases in more
than 10 months on Friday, with more than 28 million people under
lockdown, is dampening risk-appetite across the board.

(Stefano Rebaudo)

*****

More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.